Breast cancer treatment: A phased approach to implementation.
breast cancer
cancer center of excellence
centralized care
decentralized care
dissemination and implementation science
early diagnosis
health disparities
low- and middle-income countries (LMICs)
multidisciplinary evaluation
phased implementation
resource-stratification
supportive and palliative care
treatment
underserved communities
Journal
Cancer
ISSN: 1097-0142
Titre abrégé: Cancer
Pays: United States
ID NLM: 0374236
Informations de publication
Date de publication:
15 05 2020
15 05 2020
Historique:
received:
10
02
2020
revised:
31
03
2020
accepted:
31
03
2020
entrez:
30
4
2020
pubmed:
30
4
2020
medline:
22
5
2021
Statut:
ppublish
Résumé
Optimal treatment outcomes for breast cancer are dependent on a timely diagnosis followed by an organized, multidisciplinary approach to care. However, in many low- and middle-income countries, effective care management pathways can be difficult to follow because of financial constraints, a lack of resources, an insufficiently trained workforce, and/or poor infrastructure. On the basis of prior work by the Breast Health Global Initiative, this article proposes a phased implementation strategy for developing sustainable approaches to enhancing patient care in limited-resource settings by creating roadmaps that are individualized and adapted to the baseline environment. This strategy proposes that, after a situational analysis, implementation phases begin with bolstering palliative care capacity, especially in settings where a late-stage diagnosis is common. This is followed by strengthening the patient pathway, with consideration given to a dynamic balance between centralization of services into centers of excellence to achieve better quality and decentralization of services to increase patient access. The use of resource checklists ensures that comprehensive therapy or palliative care can be delivered safely and effectively. Episodic or continuous monitoring with established process and quality metrics facilitates ongoing assessment, which should drive continual process improvements. A series of case studies provides a snapshot of country experiences with enhancing patient care, including the implementation of national cancer control plans in Kenya, palliative care in Romania, the introduction of a 1-stop clinic for diagnosis in Brazil, the surgical management of breast cancer in India, and the establishment of a women's cancer center in Ghana.
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
2365-2378Subventions
Organisme : Novartis
Organisme : Fred Hutchinson Cancer Research Center
Organisme : National Comprehensive Cancer Network
Organisme : National Breast Cancer Foundation
Organisme : Susan G. Komen
ID : GSP18BHGI001
Pays : United States
Organisme : Susan G. Komen
ID : SAC170082
Pays : United States
Organisme : NCI NIH HHS
ID : 1R13CA224776-01A1
Pays : United States
Organisme : Pfizer
Organisme : American Society of Clinical Oncology
Organisme : American Society of Clinical Pathology
Organisme : Journal of Global Oncology
Organisme : pH Trust
Organisme : Seattle Cancer Care Alliance
Organisme : Union for International Cancer Control
Organisme : University of Washington
Organisme : Cepheid
Organisme : UE LifeSciences
Organisme : GE Healthcare
Informations de copyright
© 2020 American Cancer Society.
Références
Ginsburg O, Yip CH, Brooks A, et al. Breast cancer early detection: a phased approach to implementation. Cancer. 2020;126(suppl):2365-2378.
Anglade F, Milner DA, Brock JE. Can pathology diagnostics for cancer be stratified and serve global health? Cancer. 2020;126(suppl):2431-2438.
Unger-Saldana K, Miranda A, Zarco-Espinosa G, Mainero-Ratchelous F, Bargallo-Rocha E, Miguel Lazaro-LeonJ. Health system delay and its effect on clinical stage of breast cancer: multicenter study. Cancer. 2015;121:2198-2206.
Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999;353:1119-1126.
Anderson BO, Cazap E, El Saghir NS, et al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol. 2011;12:387-398.
Rositch AF, Unger-Saldaña K, DeBoer RJ, Ng’ang’a A, Weiner BJ. The role of dissemination and implementation science in global breast cancer control programs: frameworks, methods, and examples. Cancer. 2020;126(suppl):2394-2404.
Duggan C, Dvaladze AL, Tsu V, et al. Resource-stratified implementation of a community-based breast cancer management programme in Peru. Lancet Oncol. 2017;18:e607-e617.
Eniu A, Carlson RW, El Saghir NS, et al. Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation. Cancer. 2008;113(8 suppl):2269-2281.
El Saghir NS, Eniu A, Carlson RW, Aziz Z, Vorobiof D, Hortobagyi GN. Locally advanced breast cancer: treatment guideline implementation with particular attention to low- and middle-income countries. Cancer. 2008;113(8 suppl):2315-2354.
Cardoso F, Bese N, Distelhorst SR, et al. Supportive care during treatment for breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast. 2013;22:593-605.
Cardoso F, Senkus E, Costa A, et al. 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4). Ann Oncol. 2018;29:1634-1657.
Distelhorst SR, Cleary JF, Ganz PA, et al. Optimisation of the continuum of supportive and palliative care for patients with breast cancer in low-income and middle-income countries: executive summary of the Breast Health Global Initiative, 2014. Lancet Oncol. 2015;16:e137-e147.
Stoltenberg M, Spence D, Daubman BR, et al. The central role of provider training in implementing resource-stratified guidelines for palliative care in LMICs: lessons from the Jamaica Cancer Care and Research Institute (JACCRI) in the Caribbean and Universidad Catolica in Latin America. Cancer. 2020;126(suppl):2448-2457.
Cardoso F, Costa A, Norton L, et al. ESO-ESMO 2nd International Consensus Guidelines for Advanced Breast Cancer (ABC2). Ann Oncol. 2014;25:1871-1888.
Knox S. The European patient advocacy perspective on specialist breast units and accreditation. Breast. 2015;24:287-289.
Lamyian M, Hydarnia A, Ahmadi F, Faghihzadeh S, Aguilar-Vafaie ME. Barriers to and factors facilitating breast cancer screening among Iranian women: a qualitative study. East Mediterr Health J. 2007;13:1160-1169.
Azenha G, Bass LP, Caleffi M, et al. The role of breast cancer civil society in different resource settings. Breast. 2011;20(suppl 2):S81-S87.
Sayed S, Moloo Z, Bird P, et al. Breast cancer diagnosis in a resource poor environment through a collaborative multidisciplinary approach: the Kenyan experience. J Clin Pathol. 2013;66:307-311.
Teshome M, Wei C, Hunt KK, Thompson A, Rodriguez K, Mittendorf EA. Use of a magnetic tracer for sentinel lymph node detection in early-stage breast cancer patients: a meta-analysis. Ann Surg Oncol. 2016;23:1508-1514.
Coufal O, Fait V, Lzicarova E, Chrenko V, Zaloudik J. SentiMag-the magnetic detection system of sentinel lymph nodes in breast cancer [in Czech]. Rozhl Chir. 2015;94:283-288.
Bese NS, Munshi A, Budrukkar A, Elzawawy A, Perez CA. Breast radiation therapy guideline implementation in low- and middle-income countries. Cancer. 2008;113(8 suppl):2305-2314.
Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233-1241.
Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227-1232.
Braunstein LZ, Taghian AG, Niemierko A, et al. Breast-cancer subtype, age, and lymph node status as predictors of local recurrence following breast-conserving therapy. Breast Cancer Res Treat. 2017;161:173-179.
Vrieling C, van Werkhoven E, Maingon P, et al. Prognostic factors for local control in breast cancer after long-term follow-up in the EORTC Boost vs No Boost Trial: a randomized clinical trial. JAMA Oncol. 2017;3:42-48.
McGale P, Taylor C, Correa C, et al; EBCTCG (Early Breast Cancer Trialists' Collaborative Group). Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials. Lancet. 2014;383:2127-2135.
Whelan TJ, Pignol JP, Levine MN, et al. Long-term results of hypofractionated radiation therapy for breast cancer. N Engl J Med. 2010;362:513-520.
Carlson RW, Scavone JL, Koh WJ, et al. NCCN Framework for Resource Stratification: a framework for providing and improving global quality oncology care. J Natl Compr Canc Netw. 2016;14:961-969.
Jazieh AR, Al-Saggabi AH, McClung M, et al. Facing the global challenges of access to cancer medication. J Glob Oncol. 2018;4:1-7.
National Cancer Institute. SEER Cancer Statistics Review, 1975-2016. Accessed April 14, 2020. https://seer.cancer.gov/csr/1975_2016/
Im SA, Lu YS, Bardia A, et al. Overall survival with ribociclib plus endocrine therapy in breast cancer. N Engl J Med. 2019;381:307-316.
Sledge GW Jr, Toi M, Neven P, et al. The effect of abemaciclib plus fulvestrant on overall survival in hormone receptor-positive, ERBB2-negative breast cancer that progressed on endocrine therapy-MONARCH 2: a randomized clinical trial. JAMA Oncol. 2020;6:116-124.
Slamon DJ, Neven P, Chia S, et al. Overall survival with ribociclib plus fulvestrant in advanced breast cancer. N Engl J Med. 2020;382:514-524.
Vanderpuye V, Grover S, Hammad N, et al. An update on the management of breast cancer in Africa. Infect Agent Cancer. 2017;12:13.
van den Beuken-van Everdingen MH, de Rijke JM, Kessels AG, Schouten HC, van Kleef M, Patijn J. Prevalence of pain in patients with cancer: a systematic review of the past 40 years. Ann Oncol. 2007;18:1437-1449.
Krakauer EL, Kwete X, Verguet S, et al. Palliative care and pain control. In: Jamison DT, Gelband H, Horton S, et al, eds. Disease Control Priorities: Improving Health and Reducing Poverty. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017, Chapter 12.
World Health Organization. WHO Guidelines for the Pharmacological and Radiotherapeutic Management of Cancer Pain in Adults and Adolescents. Geneva: World Health Organization; 2018.
Cherny NI, Sullivan R, Torode J, Saar M, Eniu A. ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe. Ann Oncol. 2017;28:2633-2647.
Tabernero J, Vyas M, Giuliani R, et al. Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers. ESMO Open. 2016;1:e000142.
World Health Organization. World Health Organization Model List of Essential Medicines, 21st List, 2019. Geneva: World Health Organization; 2019.
Robertson J, Barr R, Shulman LN, Forte GB, Magrini N. Essential medicines for cancer: WHO recommendations and national priorities. Bull World Health Organ. 2016;94:735-742.
Shulman LN, Wagner CM, Barr R, et al. Proposing essential medicines to treat cancer: methodologies, processes, and outcomes. J Clin Oncol. 2016;34:69-75.
Eniu A, Torode J, Magrini N, Bricalli G. Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines. ESMO Open. 2016;1:e000030.
Cherny N, Sullivan R, Torode J, Saar M, Eniu A. ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe. Ann Oncol. 2016;27:1423-1443.
Cortes J, Perez-Garcia JM, Llombart-Cussac A, Saghir N. Enhancing global access to cancer medicines. CA Cancer J Clin. Published online February 18, 2020. doi:10.3322/caac.21597
El Saghir NS, Charara RN, Kreidieh FY, et al. Global practice and efficiency of multidisciplinary tumor boards: results of an American Society of Clinical Oncology international survey. J Glob Oncol. 2015;1:57-64.
Independent Cancer Taskforce. Achieving World-Class Cancer Outcomes: A Strategy for England 2015-2020. Accesssed April 14, 2020. http://bit.ly/1Idwf5W
Swarm RA, Dans M. NCCN frameworks for resource stratification of NCCN guidelines: adult cancer pain and palliative care. J Natl Compr Canc Netw. 2018;16:628-631.
Koh WJ, Anderson BO, Carlson RW. NCCN resource-stratified and harmonized guidelines-a paradigm for optimizing global cancer care. Cancer. 2020;126(Suppl):2416-2423.
Horton S, Camacho Rodriguez R, Anderson BO, et al. Health system strengthening: integration of breast cancer care for improved outcomes. Cancer. 2020;126(Suppl):2353-2364.
World Health Organization. Palliative care. Accessed April 14, 2020. https://www.who.int/news-room/fact-sheets/detail/palliative-care
Centeno C, Sitte T, de Lima L, et al. White paper for global palliative care advocacy: recommendations from a PAL-LIFE expert advisory group of the Pontifical Academy for Life, Vatican City. J Palliat Med. 2018;21:1389-1397.
Mosoiu D, Mitrea N, Dumitrescu M. Palliative care in Romania. J Pain Symptom Manage. 2018;55:S67-S76.
Lynch T, Connor S, Clark D. Mapping levels of palliative care development: a global update. J Pain Symptom Manage. 2013;45:1094-1106.
Hawley P. Barriers to access to palliative care. Palliat Care. 2017;10:1178224216688887.
Ganz PA, Yip CH, Gralow JR, et al. Supportive care after curative treatment for breast cancer (survivorship care): resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast. 2013;22:606-615.
Cleary J, Ddungu H, Distelhorst SR, et al. Supportive and palliative care for metastatic breast cancer: resource allocations in low- and middle-income countries. A Breast Health Global Initiative 2013 consensus statement. Breast. 2013;22:616-627.
Atieno OM, Opanga S, Martin A, Kurdi A, Godman B. Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future. J Med Econ. 2018;21:878-887.
World Bank. GNI, Atlas method (current US$). Accessed April 14, 2020. https://data.worldbank.org/indicator/NY.GNP.ATLS.CD
Jamison DT, Alwan A, Mock CN, et al. Universal health coverage and intersectoral action for health: key messages from Disease Control Priorities, 3rd edition. Lancet. 2018;391:1108-1120.
Carlson RW, Anderson BO, Chopra R, et al. Treatment of breast cancer in countries with limited resources. Breast J. 2003;9(suppl 2):S67-S74.
Eniu A, Carlson RW, Aziz Z, et al. Breast cancer in limited-resource countries: treatment and allocation of resources. Breast J. 2006;12(suppl 1):S38-S53.
Duggan C, Cruz TA, Porto MRT, et al. Improving breast health care in the State of Sergipe, Brazil: a commentary. J Glob Oncol. 2018;4:1-3.
Agarwal G, Rajan S, Gambhir S, Lal P, Krishnani N, Kheruka S. A comparative validation of primary surgical versus post-neo-adjuvant chemotherapy sentinel lymph node biopsy for stage III breast cancers. World J Surg. 2016;40:1583-1589.
Kumar A, Bhagabaty SM, Tripathy JP, Selvaraj K, Purkayastha J, Singh R. Delays in diagnosis and treatment of breast cancer and the pathways of care: a mixed methods study from a tertiary cancer centre in North East India. Asian Pac J Cancer Prev. 2019;20:3711-3721.
Pramesh CS, Badwe RA, Borthakur BB, et al. Delivery of affordable and equitable cancer care in India. Lancet Oncol. 2014;15:e223-e233.
Ghosh J, Gupta S, Desai S, et al. Estrogen, progesterone and HER2 receptor expression in breast tumors of patients, and their usage of HER2-targeted therapy, in a tertiary care centre in India. Indian J Cancer. 2011;48:391-396.
Singh KR, Agarwal G, Nanda G, et al. Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage. World J Surg. 2014;38:1084-1092.
Gupta S, Rastogi K, Bhatnagar AR, Singh D, Gupta K, Choudhary AS. Compliance to radiotherapy: a tertiary care center experience. Indian J Cancer. 2018;55:166-169.
Chatterjee S, Arunsingh M, Agrawal S, et al. Outcomes following a moderately hypofractionated adjuvant radiation (START B type) schedule for breast cancer in an unscreened non-Caucasian population. Clin Oncol (R Coll Radiol). 2016;28:e165-e172.
Duggan C, Dvaladze A, Scheel JR, Stevens LM, Anderson BO. Situational analysis of breast healthcare systems: context matters. Cancer. 2020;126(suppl):2405-2415.
World Health Organization. WHO List of Priority Medical Devices for Cancer Management. Geneva: World Health Organization; 2017.
Schleimer LE, Keating NL, Shulman LN, et al. Review of quality measures for breast cancer care by country income level. J Glob Oncol. 2018;4(suppl 3):41s.
DeBoer RJ, Ndumbalo J, Buckle G, et al. Implementation of guideline-based clinical practice at Ocean Road Cancer Institute in Tanzania. J Glob Oncol. 2018;4(suppl 3):12s.
O’Neil DS, Keating NL, Dusengimana JMV, et al. Quality of breast cancer treatment at a rural cancer center in Rwanda. J Glob Oncol. 2017;4:1-11.
Harford J, Azavedo E, Fischietto M; Breast Health Global Initiative Healthcare Systems Panel. Guideline implementation for breast healthcare in low- and middle-income countries: breast healthcare program resource allocation. Cancer. 2008;113(8 suppl):2282-2296.